Abstract
Methods: Baseline plus 6 and 12 month follow up data collected as part of an HIV prevention intervention trial were utilised. The baseline sample consisted of 522 African-American females, 14–18 years of age. Recruitment sites were located in low income neighbourhoods of Birmingham, Alabama, characterised by high rates of unemployment, substance abuse, violence, teenage pregnancy, and sexually transmitted infections. Self administered vaginal swab specimens were cultured for T vaginalis. Baseline measures collected as part of a self administered survey and face to face interviews were used to predict subsequent infection with T vaginalis at any of the three assessment periods conducted over the span of 1 year.
Results: At baseline, 12.9% were diagnosed with T vaginalis. At the 6 and 12 month follow ups, T vaginalis was diagnosed in 8.9% and 10.2%, respectively. The strongest multivariate predictor of T vaginalis infection was biologically confirmed marijuana use; those using marijuana were more than six times as likely to test positive for T vaginalis (adjusted odds ratio (AOR) = 6.2, p = 0.0003). Other multivariate predictors were reporting that typical sex partners were at least 5 years older (AOR = 2.6; p = 0.005), reporting sex with non-steady partners (AOR = 1.9; p = 0.02), and history of delinquency (AOR = 1.3; p = 0.02). The odds of testing positive increased by 31% for every one unit increase on a six item scale measure of delinquency.
Conclusions: Infection with T vaginalis was common and significant multivariate predictors comprised a constellation of problem behaviours, each of which are potentially amenable to behavioural intervention.
Full Text
The Full Text of this article is available as a PDF (115.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cates W., Jr Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis. 1999 Apr;26(4 Suppl):S2–S7. doi: 10.1097/00007435-199904001-00002. [DOI] [PubMed] [Google Scholar]
- Cotch M. F., Pastorek J. G., 2nd, Nugent R. P., Hillier S. L., Gibbs R. S., Martin D. H., Eschenbach D. A., Edelman R., Carey J. C., Regan J. A. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997 Jul;24(6):353–360. doi: 10.1097/00007435-199707000-00008. [DOI] [PubMed] [Google Scholar]
- Darroch J. E., Landry D. J., Oslak S. Age differences between sexual partners in the United States. Fam Plann Perspect. 1999 Jul-Aug;31(4):160–167. [PubMed] [Google Scholar]
- Foltz R. L., Sunshine I. Comparison of a TLC method with EMIT and GC/MS for detection of cannabinoids in urine. J Anal Toxicol. 1990 Nov-Dec;14(6):375–378. doi: 10.1093/jat/14.6.375. [DOI] [PubMed] [Google Scholar]
- Fortenberry J. D., Brizendine E. J., Katz B. P., Wools K. K., Blythe M. J., Orr D. P. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex Transm Dis. 1999 Jan;26(1):26–32. doi: 10.1097/00007435-199901000-00005. [DOI] [PubMed] [Google Scholar]
- Heine P., McGregor J. A. Trichomonas vaginalis: a reemerging pathogen. Clin Obstet Gynecol. 1993 Mar;36(1):137–144. doi: 10.1097/00003081-199303000-00019. [DOI] [PubMed] [Google Scholar]
- Hook E. W., 3rd Trichomonas vaginalis--no longer a minor STD. Sex Transm Dis. 1999 Aug;26(7):388–389. doi: 10.1097/00007435-199908000-00004. [DOI] [PubMed] [Google Scholar]
- Joyner J. L., Douglas J. M., Jr, Ragsdale S., Foster M., Judson F. N. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex Transm Dis. 2000 Apr;27(4):236–240. doi: 10.1097/00007435-200004000-00010. [DOI] [PubMed] [Google Scholar]
- Laga M., Manoka A., Kivuvu M., Malele B., Tuliza M., Nzila N., Goeman J., Behets F., Batter V., Alary M. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993 Jan;7(1):95–102. doi: 10.1097/00002030-199301000-00015. [DOI] [PubMed] [Google Scholar]
- Manning W. D., Longmore M. A., Giordano P. C. The relationship context of contraceptive use at first intercourse. Fam Plann Perspect. 2000 May-Jun;32(3):104–110. [PubMed] [Google Scholar]
- Miller K. S., Clark L. F., Moore J. S. Sexual initiation with older male partners and subsequent HIV risk behavior among female adolescents. Fam Plann Perspect. 1997 Sep-Oct;29(5):212–214. [PubMed] [Google Scholar]
- Shuter J., Bell D., Graham D., Holbrook K. A., Bellin E. Y. Rates of and risk factors for trichomoniasis among pregnant inmates in New York City. Sex Transm Dis. 1998 Jul;25(6):303–307. doi: 10.1097/00007435-199807000-00006. [DOI] [PubMed] [Google Scholar]
- Sorvillo F., Kerndt P. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet. 1998 Jan 17;351(9097):213–214. doi: 10.1016/S0140-6736(05)78181-2. [DOI] [PubMed] [Google Scholar]
- St Lawrence J. S., Chapdelaine A. P., Devieux J. G., O'Bannon R. E., 3rd, Brasfield T. L., Eldridge G. D. Measuring perceived barriers to condom use: psychometric evaluation of the Condom Barriers Scale. Assessment. 1999 Dec;6(4):391–404. doi: 10.1177/107319119900600409. [DOI] [PubMed] [Google Scholar]
- Sutton M. Y., Sternberg M., Nsuami M., Behets F., Nelson A. M., St Louis M. E. Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected congolese women: prevalence, risk factors, and association with low birth weight. Am J Obstet Gynecol. 1999 Sep;181(3):656–662. doi: 10.1016/s0002-9378(99)70509-0. [DOI] [PubMed] [Google Scholar]
- Valleroy L. A., MacKellar D. A., Karon J. M., Janssen R. S., Hayman C. R. HIV infection in disadvantaged out-of-school youth: prevalence for U.S. Job Corps entrants, 1990 through 1996. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):67–73. doi: 10.1097/00042560-199809010-00011. [DOI] [PubMed] [Google Scholar]
- Viikki M., Pukkala E., Nieminen P., Hakama M. Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol. 2000;39(1):71–75. doi: 10.1080/028418600431003. [DOI] [PubMed] [Google Scholar]
- Wasserheit J. N. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992 Mar-Apr;19(2):61–77. [PubMed] [Google Scholar]